Manuel Balbuena is a Business Development Director in Cell & Gene Therapy for AGC Biologics. Previously, Manuel held positions at Patheon and Novasep, focusing on Viral Vector services. Additionally, Manuel has experience in the pharmaceutical market with Waters Corporation and as an R&D Junior Scientist at DIAGAST. Manuel holds an M.B.A. from ESSEC Business School and Mannheim Business School, as well as a Master's degree in Protein Engineering from Institut national polytechnique de Lorraine and Biochemistry from Université Henri Poincaré, Nancy 1.
May, 2022 - present